Get the Stockscreener App
9.68
2.81%
-0.28
After Hours:
9.87
0.19
+1.96%
Cartesian Therapeutics Inc stock is traded at $9.68, with a volume of 61,134.
It is down -2.81% in the last 24 hours and down -14.56% over the past month.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
See More
Previous Close:
$9.96
Open:
$9.99
24h Volume:
61,134
Relative Volume:
1.03
Market Cap:
$251.70M
Revenue:
$26.00M
Net Income/Loss:
$-219.71M
P/E Ratio:
-0.1944
EPS:
-49.8
Net Cash Flow:
$-51.37M
1W Performance:
-9.02%
1M Performance:
-14.56%
6M Performance:
-44.62%
1Y Performance:
-39.76%
1-Day Range:
$9.55
$10.48
1-Week Range:
$9.55
$10.74
52-Week Range:
$8.46
$26.50
Cartesian Therapeutics Inc Stock (RNAC) Company Profile
Name
Cartesian Therapeutics Inc
Sector
Industry
Phone
301-348-8698
Address
7495 NEW HORIZON WAY, FREDERICK
Compare RNAC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RNAC
Cartesian Therapeutics Inc
|
9.68 | 255.08M | 26.00M | -219.71M | -51.37M | -49.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Wedbush | Outperform |
| Dec-19-24 | Initiated | BTIG Research | Buy |
| Aug-06-24 | Initiated | TD Cowen | Buy |
| Jul-02-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Jun-04-24 | Initiated | Oppenheimer | Outperform |
| May-24-24 | Initiated | Mizuho | Buy |
| Apr-23-24 | Reiterated | H.C. Wainwright | Buy |
| Apr-23-24 | Initiated | Leerink Partners | Outperform |
| Aug-18-23 | Downgrade | SVB Securities | Outperform → Market Perform |
| Jun-14-22 | Reiterated | Needham | Buy |
| Jun-06-22 | Initiated | SVB Leerink | Outperform |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| Jan-26-21 | Upgrade | Mizuho | Neutral → Buy |
| Oct-01-20 | Downgrade | Mizuho | Buy → Neutral |
| Oct-01-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-12-20 | Downgrade | Stifel | Buy → Hold |
| Apr-28-20 | Initiated | H.C. Wainwright | Buy |
| Jan-29-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-21-20 | Initiated | William Blair | Outperform |
| Jun-27-18 | Initiated | Janney | Buy |
| Mar-30-17 | Reiterated | UBS | Buy |
View All
Cartesian Therapeutics Inc Stock (RNAC) Latest News
Best data tools to analyze Cartesian Therapeutics Inc. stockMarket Movers & AI Driven Stock Reports - Newser
Why Cartesian Therapeutics Inc. stock could rally in 2025Market Trend Report & Smart Money Movement Tracker - baoquankhu1.vn
Is Cartesian Therapeutics Inc. reversing from oversold territoryJuly 2025 Retail & Weekly Momentum Picks - Newser
Sector ETF performance correlation with Cartesian Therapeutics Inc.Portfolio Growth Summary & High Accuracy Buy Signal Tips - Newser
What candlestick patterns are forming on Cartesian Therapeutics Inc.Weekly Market Outlook & Technical Confirmation Trade Alerts - Newser
Custom watchlist performance reports with Cartesian Therapeutics Inc.Quarterly Earnings Report & Risk Managed Investment Strategies - Newser
Candlestick signals on Cartesian Therapeutics Inc. stock todayCEO Change & Consistent Growth Equity Picks - Newser
How moving averages guide Cartesian Therapeutics Inc. tradingEarnings Growth Report & Community Verified Swing Trade Signals - Newser
Short interest data insights for Cartesian Therapeutics Inc.July 2025 Momentum & Safe Investment Capital Preservation Plans - Newser
Is Cartesian Therapeutics Inc. stock bottoming outJuly 2025 Summary & Weekly Stock Performance Updates - Newser
News impact scoring models applied to Cartesian Therapeutics Inc.July 2025 Trade Ideas & Stock Timing and Entry Methods - Newser
What momentum shifts mean for Cartesian Therapeutics Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - Newser
Can you recover from losses in Cartesian Therapeutics Inc.Market Activity Recap & Verified Entry Point Signals - Newser
Is Cartesian Therapeutics Inc. showing signs of accumulationPortfolio Return Summary & Low Risk Investment Opportunities - Newser
Can Cartesian Therapeutics Inc. rally from current levels2025 Big Picture & Reliable Intraday Trade Plans - Newser
Combining machine learning predictions for Cartesian Therapeutics Inc.Portfolio Return Summary & Expert-Curated Trade Recommendations - Newser
Published on: 2025-09-11 11:55:35 - Newser
27,869 Shares in Cartesian Therapeutics, Inc. $RNAC Bought by Nuveen LLC - MarketBeat
What’s next for Cartesian Therapeutics Inc. stock priceJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - Newser
Measuring Cartesian Therapeutics Inc.’s beta against major indicesJuly 2025 Spike Watch & Community Consensus Trade Signals - Newser
Published on: 2025-09-10 04:20:46 - Newser
Using economic indicators to assess Cartesian Therapeutics Inc. potentialDay Trade & Real-Time Price Movement Reports - Newser
Predicting Cartesian Therapeutics Inc. trend using moving averages2025 Top Decliners & Free High Return Stock Watch Alerts - Newser
Will Cartesian Therapeutics Inc. continue its uptrendPrice Action & Daily Stock Momentum Reports - Newser
Is Cartesian Therapeutics Inc. a defensive stockMarket Volume Report & Weekly Watchlist for Hot Stocks - Lancaster City Council
What technical models suggest about Cartesian Therapeutics Inc.’s comebackTrend Reversal & Daily Volume Surge Signals - Newser
Cartesian Therapeutics Inc. stock outlook for YEARQuarterly Portfolio Report & Consistent Return Strategy Ideas - Newser
Cartesian Therapeutics Inc. recovery potential after sell offEarnings Risk Report & Technical Confirmation Alerts - Newser
Is Cartesian Therapeutics Inc. the Top Chart Pick This WeekPortfolio Gains Summary & Growth-Oriented Investment Plans - beatles.ru
cartesian therapeutics inc. stock volume spike explainedJuly 2025 Weekly Recap & Fast Momentum Entry Tips - Newser
Cartesian Therapeutics Inc Stock (RNAC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):